down arrow

Transgene Biotek

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE773D01018
  • NSEID:
  • BSEID: 526139
INR
3.65
0.00 (0.00%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.94 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3.643.65

52 Week

3.2210.84
Valuation
Technical
Day's Volume

CASH

8.94 k (-49.03%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

23.64%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 28 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.29

stock-summary
Return on Equity

-2.40%

stock-summary
Price to Book

2.55

Revenue and Profits (1 Year):
Net Sales:
0 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-53.02%
0%
-53.02%
1 Year
-54.71%
0%
-54.71%
2 Years
45.42%
0%
45.42%
3 Years
-8.75%
0%
-8.75%
4 Years
-36.19%
0%
-36.19%
5 Years
18.12%
0%
18.12%

Transgene Biotek for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.40%
EBIT Growth (5y)
13.86%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-24.81%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
55
Price to Book Value
2.55
EV to EBIT
-41.60
EV to EBITDA
-41.60
EV to Capital Employed
1.68
EV to Sales
41.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.84%
ROE (Latest)
-2.40%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Dr K Koteswara Rao (21.89%)

Highest Public shareholder

None

Individual Investors Holdings

71.87%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 33.33% vs 20.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -28.57% vs -135.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.08",
          "val2": "0.06",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.09",
          "val2": "-0.08",
          "chgp": "-12.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.02",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.09",
          "val2": "-0.07",
          "chgp": "-28.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-112.50%",
          "val2": "-133.33%",
          "chgp": "20.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.11",
          "val2": "0.06",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.48",
          "val2": "-0.67",
          "chgp": "28.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.09",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.13",
          "val2": "-3.16",
          "chgp": "104.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-436.36%",
          "val2": "-1,116.67%",
          "chgp": "680.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 216.67% vs 0.00% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 100.88% vs 42.17% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.19",
          "val2": "0.06",
          "chgp": "216.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.57",
          "val2": "-0.81",
          "chgp": "29.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.14",
          "chgp": "-64.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.04",
          "val2": "-4.54",
          "chgp": "100.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-300.00%",
          "val2": "-1,350.00%",
          "chgp": "1,050.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 283.33% vs -33.33% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 89.02% vs 42.21% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.23",
          "val2": "0.06",
          "chgp": "283.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.62",
          "val2": "-1.05",
          "chgp": "40.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.13",
          "val2": "0.18",
          "chgp": "-27.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.66",
          "val2": "-6.01",
          "chgp": "89.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-269.57%",
          "val2": "-1,750.00%",
          "chgp": "1,480.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
0.08
0.06
33.33%
Operating Profit (PBDIT) excl Other Income
-0.09
-0.08
-12.50%
Interest
0.02
0.02
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.09
-0.07
-28.57%
Operating Profit Margin (Excl OI)
-112.50%
-133.33%
20.83%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 33.33% vs 20.00% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -28.57% vs -135.00% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'22
Change(%)
Net Sales
0.11
0.06
83.33%
Operating Profit (PBDIT) excl Other Income
-0.48
-0.67
28.36%
Interest
0.03
0.09
-66.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.13
-3.16
104.11%
Operating Profit Margin (Excl OI)
-436.36%
-1,116.67%
680.31%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'22
Change(%)
Net Sales
0.19
0.06
216.67%
Operating Profit (PBDIT) excl Other Income
-0.57
-0.81
29.63%
Interest
0.05
0.14
-64.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.04
-4.54
100.88%
Operating Profit Margin (Excl OI)
-300.00%
-1,350.00%
1,050.00%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 216.67% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 100.88% vs 42.17% in Dec 2022

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
0.23
0.06
283.33%
Operating Profit (PBDIT) excl Other Income
-0.62
-1.05
40.95%
Interest
0.13
0.18
-27.78%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.66
-6.01
89.02%
Operating Profit Margin (Excl OI)
-269.57%
-1,750.00%
1,480.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 283.33% vs -33.33% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 89.02% vs 42.21% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Transgene Biotek Ltd stock-summary
stock-summary
Transgene Biotek Ltd
Micro Cap
Hospital & Healthcare Services
Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
Company Coordinates stock-summary
Company Details
Plot No 69 & 70 IDA Bollaram , Sangareddy Telangana : 502325
stock-summary
Tel:
stock-summary
http://www.transgenebiotek.com
stock-summary
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."